10.6084/m9.figshare.5793861.v4 Gregory J. Feldman Gregory J. Feldman Ana R. Sousa Ana R. Sousa David A. Lipson David A. Lipson Lee Tombs Lee Tombs Neil Barnes Neil Barnes John H. Riley John H. Riley Sadhana Patel Sadhana Patel Ian Naya Ian Naya Chris Compton Chris Compton Bernardino Alcázar Navarrete Bernardino Alcázar Navarrete Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study Adis Journals 2018 Bronchodilation COPD LAMA LABA Long-acting muscarinic antagonist Long-acting β2-agonist Olodaterol Tiotropium Umeclidinium Vilanterol 2018-01-17 14:55:41 Dataset https://adisjournals.figshare.com/articles/dataset/Comparative_Efficacy_of_Once-Daily_Umeclidinium_Vilanterol_and_Tiotropium_Olodaterol_Therapy_in_Symptomatic_Chronic_Obstructive_Pulmonary_Disease_A_Randomized_Study/5793861 <h2>Article full text</h2><p>The full text of this article can be found here <a href="https://link.springer.com/article/10.1007/s12325-017-0626-4">https://link.springer.com/article/10.1007/s12325-017-0626-4</a>.</p><h2>Provide enhanced content for this article</h2><p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/”mailto:adisrapidplus@springer.com”">adisrapidplus@springer.com</a>.</p><p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p><p>Other enhanced features include, but are not limited to:</p><ul><li>Summary slides</li><li>Slide decks</li><li>Videos and animations</li><li>Audio abstracts</li><li>Audio slides</li></ul>